In this study, researchers want to see if a medicine called milvexian can help prevent another stroke in people who've had an ischemic stroke (a type of stroke where a blood clot blocks blood flow to the brain) or a transient ischemic attack (TIA) (often called a mini-stroke, where stroke-like symptoms happen but go away). The study compares milvexian to a placebo (a pill that doesn't have any medicine in it) to check if it reduces stroke risk.
Participants need to have had a stroke or TIA with certain conditions, like specific scores on medical tests or treatments already done. They should start the study soon after their stroke or TIA. Women must not be pregnant or breastfeeding, and everyone should follow specific lifestyle rules.
People cannot join if they have certain bleeding risks, liver disease, or are allergic to the study medicine.
- Study length: Participants will be monitored for any stroke recurrence risks.
- Visits needed: Multiple visits for monitoring and testing.
- Compensation: May be available based on study guidelines.